Eagle Bay Advisors LLC Abb Vie Inc. Transaction History

Eagle Bay Advisors LLC

$170 Million
Q3 2024

A detailed history of Eagle Bay Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 9,721 shares of ABBV stock, worth $1.66 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

9,721

Previous 9,714 0.07%

Holding current value

$1.66 Million

Previous $1.67 Million 15.19%

% of portfolio

1.13%

Previous 1.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$163.84 - $199.33 $1,146 - $1,395	7 Added 0.07%	9,721 $1.92 Million
Q2 2024 Jul 26, 2024	BUY	$154.79 - $180.76 $58,510 - $68,327	378 Added 4.05%	9,714 $1.67 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $85,343 - $97,241	-534 Reduced 5.41%	9,336 $1.7 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $52,976 - $59,663	-385 Reduced 3.75%	9,870 $1.53 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $58,913 - $68,200	441 Added 4.49%	10,255 $1.53 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $2,915 - $3,627	-22 Reduced 0.22%	9,814 $1.32 Million
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $62,037 - $71,445	-429 Reduced 4.18%	9,836 $1.57 Million
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $170,536 - $204,517	-1,233 Reduced 10.72%	10,265 $0
Q3 2022 Nov 22, 2022	SELL	$134.21 - $153.93 $39,189 - $44,947	-292 Reduced 2.48%	11,498 $1.54 Million
Q2 2022 Aug 19, 2022	BUY	$137.62 - $174.96 $45,276 - $57,561	329 Added 2.87%	11,790 $1.81 Billion
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $16,893 - $20,960	128 Added 1.13%	11,461 $1.86 Million
Q4 2021 Jan 21, 2022	SELL	$107.43 - $135.93 $265,996 - $336,562	-2,476 Reduced 17.93%	11,333 $1.54 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $230,994 - $262,213	2,171 Added 18.65%	13,809 $1.49 Million
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $1.22 Million - $1.36 Million	11,638 New	11,638 $1.33 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.

Account

Eagle Bay Advisors LLC Abb Vie Inc. Transaction History